Braxton, David R <br/><br/>
Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".  [electronic resource] 

 -  Human pathology  Apr 2017 
 - 232-241 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1532-8392 
<br/><br/><label>Standard No.: </label>10.1016/j.humpath.2017.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--chemistry<br/>Adolescent<br/>Adult<br/>Bile Duct Neoplasms--chemistry<br/>Biomarkers, Tumor--analysis<br/>Cholangiocarcinoma--chemistry<br/>Cytogenetic Analysis<br/>Diagnosis, Differential<br/>Fatal Outcome<br/>Female<br/>Gene Expression Profiling<br/>Genetic Predisposition to Disease<br/>Humans<br/>Immunohistochemistry<br/>Inhibins--analysis<br/>Liver Neoplasms--chemistry<br/>Molecular Diagnostic Techniques<br/>Neuroendocrine Tumors--chemistry<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Predictive Value of Tests<br/>Terminology as Topic<br/>Treatment Outcome